Tuning Pharmacokinetics and Biodistribution of a Targeted Drug Delivery System Through Incorporation of a Passive Targeting Component

per Kudgus, Rachel A., Walden, Chad A., McGovern, Renee M., Reid, Joel M., Robertson, J. David, Mukherjee, Priyabrata
Publicat 2014

Neuroprotection mediated by inhibition of calpain during acute viral encephalitis

per Howe, Charles L., LaFrance-Corey, Reghann G., Mirchia, Kanish, Sauer, Brian M., McGovern, Renee M., Reid, Joel M., Buenz, Eric J.
Publicat a Sci Rep (2016)

Comparative Bioavailability of Sulindac in Capsule and Tablet Formulations

per Reid, Joel M., Mandrekar, Sumithra J., Carlson, Elsa C., Harmsen, W. Scott, Green, Erin M., McGovern, Renee M., Szabo, Eva, Ames, Matthew M., Boring, Daniel, Limburg, Paul J.
Publicat 2008

Skeletal and Uterotrophic Effects of Endoxifen in Female Rats

per Gingery, Anne, Iwaniec, Urszula T., Subramaniam, Malayannan, Turner, Russell T., Pitel, Kevin S., McGovern, Renee M., Reid, Joel M., Marler, Ronald J., Ingle, James N., Goetz, Matthew P., Hawse, John R.
Publicat a Endocrinology (2017)

A Pediatric Phase 1 Trial Of Vorinostat And Temozolomide In Relapsed Or Refractory Primary Brain Or Spinal Cord Tumors: A Children’s Oncology Group Phase 1 Consortium Study

per Hummel, Trent R., Wagner, Lars, Ahern, Charlotte, Fouladi, Maryam, Reid, Joel M., McGovern, Renee M., Ames, Matthew M., Gilbertson, Richard J., Horton, Terzah, Ingle, Ashish M., Weigel, Brenda, Blaney, Susan M.
Publicat 2013

A Phase I Trial of Vorinostat and Bortezomib in Children with Refractory or Recurrent Solid Tumors: A Children’s Oncology Group Phase I Consortium Study (ADVL0916)

per Muscal, Jodi A., Thompson, Patrick A., Horton, Terzah M., Ingle, Ashish M., Ahern, Charlotte H., McGovern, Renee M., Reid, Joel M., Ames, Matthew M., Espinoza-Delgado, Igor, Weigel, Brenda J., Blaney, Susan M.
Publicat 2012

A Phase I Study of Intermittently Dosed Vorinostat in Combination with Bortezomib in Patients with Advanced Solid Tumors

per Deming, Dustin A., Ninan, Jacob, Bailey, Howard H., Kolesar, Jill M., Eickhoff, Jens, Reid, Joel, Ames, Matthew M., McGovern, Renee M., Alberti, Dona, Marnocha, Rebecca, Espinoza-Delgado, Igor, Wright, John, Wilding, George, Schelman, William R.
Publicat 2013

A Phase I Trial Of MK-2206 In Children with Refractory Malignancies: A Children's Oncology Group Study

per Fouladi, Maryam, Perentesis, John P., Phillips, Christine L., Leary, Sarah, Reid, Joel M., McGovern, Renee M., Ingle, Ashish M., Ahern, Charlotte H., Ames, Matthew M., Houghton, Peter, Doyle, L. Austin, Weigel, Brenda, Blaney, Susan M.
Publicat a Pediatr Blood Cancer (2014)

A Phase I Trial of Vorinostat and Alvocidib in Patients with Relapsed, Refractory or Poor Prognosis Acute Leukemia, or Refractory Anemia with Excess Blasts-2

per Holkova, Beata, Supko, Jeffrey G., Ames, Matthew M., Reid, Joel M., Shapiro, Geoffrey I., Tombes, Mary Beth, Honeycutt, Connie, McGovern, Renee M., Kmieciak, Maciej, Shrader, Ellen, Wellons, Martha D., Sankala, Heidi, Roberts, John D., Grant, Steven
Publicat 2013

A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors

per Dickson, Mark Andrew, Rathkopf, Dana E., Carvajal, Richard D., Grant, Steven, Roberts, John D., Reid, Joel M., Ames, Matthew M., McGovern, Renee M., Lefkowitz, Robert A., Gonen, Mithat, Cane, Lauren M., Dials, Heather J., Schwartz, Gary K.
Publicat 2010

UGT1A1 Genotype-guided Phase I Study of Irinotecan, Oxaliplatin, and Capecitabine

per Goetz, Matthew P., McKean, Heidi A., Reid, Joel M, Mandrekar, Sumithra J., Tan, Angelina D., Kuffel, Mary A., Safgren, Stephanie L., McGovern, Renee M., Goldberg, Richard M., Grothey, Axel A., McWilliams, Robert, Erlichman, Charles, Ames, Matthew M.
Publicat 2013

A Phase I Study of Vorinostat in Combination with Bortezomib in Patients with Advanced Malignancies

per Schelman, William R., Traynor, Anne M., Holen, Kyle D., Kolesar, Jill M., Attia, Steven, Hoang, Tien, Eickhoff, Jens, Jiang, Zhisheng, Alberti, Dona, Marnocha, Rebecca, Reid, Joel M., Ames, Matthew M., McGovern, Renee M., Espinoza-Delgado, Igor, Wright, John J., Wilding, George, Bailey, Howard H.
Publicat 2013

Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: A report from the Children’s Oncolog...

per Villablanca, Judith G., London, Wendy B., Naranjo, Arlene, McGrady, Patrick, Ames, Matthew M., Reid, Joel M., McGovern, Renee M., Buhrow, Sarah A., Jackson, Hollie, Stranzinger, Enno, Kitchen, Brenda J., Sondel, Paul M., Parisi, Marguerite T., Shulkin, Barry, Yanik, Gregory A., Cohn, Susan L., Reynolds, C. Patrick
Publicat 2011

Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM

per Jaeckle, Kurt A., Ballman, Karla V., Giannini, Caterina, Schomberg, Paula J., Ames, Matthew M., Reid, Joel M., McGovern, Renee M., Safgren, Stephanie L., Galanis, Evanthia, Uhm, Joon H., Brown, Paul D., Hammack, Julie E., Arusell, Robert, Nikcevich, Daniel A., Morton, Roscoe F., Wender, Donald B., Buckner, Jan C.
Publicat 2010

Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03

per Lee, Eudocia Q., Puduvalli, Vinay K., Reid, Joel M., Kuhn, John G., Lamborn, Kathleen R., Cloughesy, Timothy F., Chang, Susan M., Drappatz, Jan, Yung, W. K. Alfred, Gilbert, Mark R., Robins, H. Ian, Lieberman, Frank S., Lassman, Andrew B., McGovern, Renee M., Xu, Jihong, Desideri, Serena, Ye, Xiabu, Ames, Matthew M., Espinoza-Delgado, Igor, Prados, Michael D., Wen, Patrick Y.
Publicat 2012

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

per Jayaraman, Swaathi, Hou, Xiaonan, Kuffel, Mary J., Suman, Vera J., Hoskin, Tanya L., Reinicke, Kathryn E., Monroe, David G., Kalari, Krishna R., Tang, Xiaojia, Zeldenrust, Megan A., Cheng, Jingfei, Bruinsma, Elizabeth S., Buhrow, Sarah A., McGovern, Renee M., Safgren, Stephanie L., Walden, Chad A., Carter, Jodi M., Reid, Joel M., Ingle, James N., Ames, Matthew M., Hawse, John R., Goetz, Matthew P.
Publicat a Breast Cancer Res (2020)

Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors

per Takebe, Naoko, Coyne, Geraldine O'Sullivan, Kummar, Shivaani, Collins, Jerry, Reid, Joel M., Piekarz, Richard, Moore, Nancy, Juwara, Lamin, Johnson, Barry C., Bishop, Rachel, Lin, Frank I., Mena, Esther, Choyke, Peter L., Lindenberg, M. Liza, Rubinstein, Larry V., Bonilla, Cecilia Monge, Goetz, Matthew P., Ames, Matthew M., McGovern, Renee M., Streicher, Howard, Covey, Joseph M., Doroshow, James H., Chen, Alice P.
Publicat a Oncotarget (2021)

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

per Goetz, Matthew P., Suman, Vera J., Reid, Joel M., Northfelt, Don W., Mahr, Michael A., Ralya, Andrew T., Kuffel, Mary, Buhrow, Sarah A., Safgren, Stephanie L., McGovern, Renee M., Black, John, Dockter, Travis, Haddad, Tufia, Erlichman, Charles, Adjei, Alex A., Visscher, Dan, Chalmers, Zachary R., Frampton, Garrett, Kipp, Benjamin R., Liu, Minetta C., Hawse, John R., Doroshow, James H., Collins, Jerry M., Streicher, Howard, Ames, Matthew M., Ingle, James N.
Publicat a J Clin Oncol (2017)